Live news related to IPSEN stock (FR0010259150): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
Ipsen reported on Thursday, April 23, a first-quarter 2026 revenue of EUR 1,074.9 million, up 22.6% at constant exchange rates. This growth, which exc…
Ipsen significantly advanced this Thursday, April 23, driven by the announcement of a first-quarter revenue increase of 22.6% at constant exchange rat…
The European Commission has granted conditional marketing authorization to Ipsen's Ojemda (tovorafenib) for treating children with pediatric low-grade…
This Wednesday afternoon, Ipsen marks one of the best performances on the SBF 120 in a slightly declining Parisian market. The French biopharmaceutica…
The share of the French pharmaceutical company is trading at €169.40 this Friday, up 4.12% from the previous day, reaching a new all-time high in the …
The pharmaceutical company's stock reached a new historical high of €167.80 this Tuesday, surpassing the previous peak achieved on April 2nd. Despite …
Ipsen announces that Beech Tree, holding 26.03% of the capital and 33.05% of the voting rights, has been granted an exemption by the Financial Markets…
The stock of the French pharmaceutical company traded at 165.20 euros this Wednesday, up 2.99% from the previous day. This increase is part of a susta…
JP Morgan ajuste sa position sur le titre Ipsen ce jeudi 26 mars 2026.
Ipsen has announced the presentation of new preclinical data for two early-stage drug candidates at the American Association of Cancer Research (AACR)…
